Location · Reno, NV
Clinical trials in Reno, NV
48 recruiting studies have a site in Reno, and 8 of them accept healthy volunteers.
48 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteersPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Pfizer
- Location
- Reno, NV + 138 other US sites
- Eligibility basics
- Ages 65+
- RecruitingHealthy volunteers
The Impact of Enhanced Music & Natural Visuals on Emotional Health
soundBrilliance LLC
- Location
- Reno, NV + 2 other US sites
- Eligibility basics
- Ages 13+
- RecruitingHealthy volunteers
Helix Research Network
Helix, Inc
- Location
- Reno, NV + 13 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Exai Bio Inc.
- Location
- Reno, NV + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular…
AbbVie
- Location
- Reno, NV + 54 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
PureTech
- Location
- Reno, NV + 15 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
MBX Biosciences
- Location
- Reno, NV + 19 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
SPYRAL GEMINI Pilot Study
Medtronic Vascular
- Location
- Reno, NV + 11 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism
Ascendis Pharma Bone Diseases A/S
- Location
- Reno, NV + 7 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Sanofi
- Location
- Reno, NV + 30 other US sites
- Eligibility basics
- Ages 60+
- RecruitingPhase 3
Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Sling Therapeutics, Inc.
- Location
- Reno, NV + 16 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
AbbVie
- Location
- Reno, NV + 29 other US sites
- Eligibility basics
- Ages 12–63
- RecruitingPhase 2
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Boehringer Ingelheim
- Location
- Reno, NV + 21 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Ambros Therapeutics, Inc.
- Location
- Reno, NV + 29 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)
Complement Therapeutics
- Location
- Reno, NV + 3 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 2
RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder
Vensica Therapeutics Ltd.
- Location
- Reno, NV + 2 other US sites
- Eligibility basics
- Ages 18–80 · Women only
- RecruitingPhase 2/Phase 3
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
AbbVie
- Location
- Reno, NV + 36 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Kallyope Inc.
- Location
- Reno, NV + 111 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Akero Therapeutics, Inc
- Location
- Reno, NV + 131 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 2
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette);
Genentech, Inc.
- Location
- Reno, NV + 14 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
Trevi Therapeutics
- Location
- Reno, NV + 21 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
4D Molecular Therapeutics
- Location
- Reno, NV + 8 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Tempus AI
- Location
- Reno, NV + 39 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Eli Lilly and Company
- Location
- Reno, NV + 68 other US sites
- Eligibility basics
- Ages 18+